LATEST ARTICLES

Access & Prescribing (Australia & Global)

Medical Cannabis Rescheduling Highlights Urgent Need for Clinician Education

Gillian Jalimnson -
Equities, Investment & Market Trends

White House National Drug Strategy Raises Alarm on High-Potency Marijuana, Affirms Federal Hemp THC Ban

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Federal Schedule III Reclassification Prompts State-Level Medical Cannabis Expansion and Regulatory Adjustments

Steven Gothrinet -
Access & Prescribing (Australia & Global)

CSQ Introduces EU GMP Addendum to Facilitate Cannabinoid Export Compliance for European Markets

Steven Gothrinet -
Australian Cannabis Policy & Law

U.S. House Advances Farm Bill, Establishing Separate Regulatory Pathways for Industrial Hemp and Cannabinoid Crops

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Exploring Medical Cannabis for Seniors: Enhancing Quality of Life in Later Years

Gillian Jalimnson -
Cannabinoid Pharmacology

Study Highlights Adverse Events Associated with Medical Cannabis Use in Minnesota Program

Gillian Jalimnson -
Australian Cannabis Policy & Law

DEA Classifies Synthetic Cannabinoid HHC as Schedule I Substance; Texas Hemp Sales Face New Rulings

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Australian Medical Cannabis Sales Decline 28.5% Amid Increased Regulatory Enforcement

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Israel Health Ministry Proposes Significant Tightening of Medical Cannabis Regulation

Steven Gothrinet -
1...192021...298Page 20 of 298

MOST POPULAR

Equities, Investment & Market Trends

US Hemp Cannabinoid  Prices In December

Steven Gothrinet -
Prices for CBD biomass in the USA remained stable in December - but still significantly lower than the December prior.Released a few days before...
Read more
Hempcrete & Sustainable Construction

Hempcrete’s Fireproof Street Cred Gets A Boost

Terry Lassitenaz -
Hempcrete's reputation for fire resistance just received a lift in the USA after formal testing was carried out.Hempcrete has traditionally been made using a...
Read more
Access & Prescribing (Australia & Global)

A Name Change For PUF Ventures Australia

Terry Lassitenaz -
PUF Ventures Australia (PUFA) announced last week it was changing its name to Solaris Nutraceuticals Pty. Ltd.“The new name reflects our focus on distinct...
Read more
Australian Cannabis Policy & Law

ECS Botanics’ Tasmanian Business Sold

Terry Lassitenaz -
Australian medical cannabis company ECS Botanics Holdings Ltd has announced it has offloaded its Tasmanian business and assets.ECS Botanics had its fingers in a...
Read more
Load more